Summary In summary, T2DM complicated by gastroparesis is a fairly common comorbidity, especially in patients with long-standing diabetes, that necessitates a careful consideration of appropriate therapy
Phase 3 trial data has now demonstrated weight loss outcomes that, in some patient groups, approach those previously only achieved through bariatric surgery
Ozempic and Race Day Fueling Fueling during long-distance events is hard enough without introducing a drug that slows digestion and reduces hunger
Their operational definitions are detailed in Additional file 1: Table S4
They gradually combine them to form phrases and sentences
During the early stages of development, tesofensine was found to be ineffective in treating neurodegenerative conditions, but it unexpectedly caused weight loss in the people who took it